Form 483

Charles River Laboratories, Inc. Form 483, 2018-06-15

FDA issued a Form 483 to Charles River Laboratories, Inc. on 2018-06-15 with 2 public-safe observations.

483· Form 483 issuedHuman Drugs2 observations

Charles River Laboratories, Inc. · Reno, United States · Issued June 15, 2018

Overview

  • 2 public-safe observations are available for this inspection.
  • 1 structured CFR citation is represented.
  • 2 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

15 Jun 2018
21 CFR 58.185(a)(9)

Final report: circumstances affecting data qual., integrity

Cited by Sandra S Saniga, Zhou Chen

15 Jun 2018
21 CFR 58.185(a)(9)

Final report: circumstances affecting data qual., integrity

Cited by Sandra S Saniga, Zhou Chen

Inspected site

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 58.185(a)(9)Cited across public-safe Form 483 observations2x

Full 483 report

Get the verbatim text of all 2 observations

The full inspection record, as Atlas holds it, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere